Quantitative aspects of perinatal lung growth

Insights

Infant lung development shows a peak in disaturated phosphatidylcholine (DSPC) around 36-41 weeks. Small-for-dates infants exhibit advanced lung maturation, while hyaline membrane disease lungs suggest early injury response.

Area of Science:

  • Neonatal physiology
  • Pulmonary development
  • Biochemistry

Background:

  • Lung development is critical for infant survival.
  • Understanding biochemical markers aids in assessing lung maturity.
  • Hyaline membrane disease (HMD) and small-for-dates (SFD) infants present unique developmental challenges.

Purpose of the Study:

  • To investigate lung composition in relation to gestational age.
  • To compare lung development in normal, HMD, and SFD infants.
  • To identify biochemical indicators of lung maturation and injury.

Main Methods:

  • Analysis of lung weight, DNA, protein, hydroxyproline, and disaturated phosphatidylcholine (DSPC) in 97 infants.
  • Comparison across a wide postconceptional age range (22-75 weeks).
  • Inclusion of normal, HMD, and SFD infant cohorts.

Main Results:

  • Lung weight and DNA relative to body weight decreased in late-term infants.
  • A peak in total lung DSPC and DSPC concentration occurred at 36-41 weeks.
  • SFD infants showed advanced maturation markers, while HMD lungs indicated early injury.

Conclusions:

  • Recurrent intrauterine stress may contribute to smaller lung size near term.
  • Lung changes in SFD infants suggest accelerated maturation.
  • Increased hydroxyproline in HMD lungs points to an early proliferative response to injury.